Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

High-resolution, all-digital microscope that applies computational methods to bring revolutionary benefits of digital microscopy to small and medium sized laboratories

Project description

Bringing digital pathology to routine diagnosis

Diagnosis of many diseases relies on slide-based biopsies. However, in many countries this requires shipment of slides to hospitals with expert pathologists, causing significant delays in diagnosis. To address this challenge, the EU-funded SCOPIO project has developed a disruptive computational method that facilitates the digitisation of whole slide images taken with cost-effective conventional hardware. The SCOPIO software overcomes the high cost of digital microscopy by allowing magnification of biopsies up to 100 times. Importantly, it supports the electronic transfer of digital images nationwide to improve pathology workflow and deliver fast diagnosis for many diseases.

Objective

Scopio Labs aims to expand the use of Whole Slide Imaging (WSI) for its application in digital pathology and is developing a digital microscopy platform capable of scanning high resolution images with low hardware costs.
Despite digital microscopy exists for decades, its use has been limited by the high prices of the technology. Our solution provides a low cost-high quality technology which will allow the implementation of WSI facilities in small hospitals and diagnostic centres. By using cutting edge principles of computational photography, we are able to enhance resolution and magnification (up to 100X) of images taken by affordable optics and mechanics through a disruptive computation method.
Biopsies are frequently used to determine different diseases as psoriasis, diabetes, hepatic diseases, infections or cancer. Every year, more than 3 million new cancers are diagnosed and cancer is causing around 1.7 million deaths worldwide. Its early diagnosis has been pointed out as a factor for increasing patient survival. Our technology upgrades the diagnosis process with substantial time savings and connects and assists pathologists and experts worldwide with its analysis software.
We estimate the total addressable market for WSI, including the sale of hardware, software and services enabled by the digitization of glass slides, to grow from $1.3B/year to $11B/year in the next decade.
We forecast that during the next five years after commercialization, we will have sold about 3,150 digital microscopes and hired 38 new employees. We will earn almost €58M profit with a ROI of 6.47. Payback will be reached already in 2021.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

SME-1 - SME instrument phase 1

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) H2020-EIC-SMEInst-2018-2020

See all projects funded under this call

Coordinator

SCOPIO LABS LTD
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 50 000,00
Address
11 TIOMKIN ST. APT.5
6578317 TEL AVIV
Israel

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 71 429,00
My booklet 0 0